← Eichor
Study identifier: NCT06435156 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes

Condition: Type 1 Diabetes · Heart Failure  ·  Sponsor: University of Dundee

PhasePhase 2
Planned participants320
Who can joinAll sexes, 18 Years to 84 Years
Healthy volunteersNo

About this study

People with type 1 diabetes sometimes develop heart failure which can cause symptoms like breathlessness, tiredness or ankle swelling, reduced quality of life and lead to being admitted to hospital or suffering potential fatal consequences. This trial is investigating if a tablet called sotagliflozin, can improve quality of life in people with type 1 diabetes and heart failure. In addition, this trial will also assess the safety and tolerability of sotagliflozin in this population. In previous trials that included people with type 2 diabetes and heart failure sotagliflozin was shown to improve patients' symptoms of heart failure, quality of life and reduce the chance of people with heart failure being admitted to hospital or dying. However, people with type 1 diabetes and heart failure were not included in these trials meaning that it is not known if these benefits also apply to this population. This trial aims to recruit 320 people with type 1 diabetes and heart failure symptoms in multiple sites in the United Kingdom (UK). This trial will compare the health and quality of life of participants who take sotagliflozin tablets with participants who take placebo tablets, which is a dummy tablet that looks the same as sotagliflozin. Participants will be randomly allocated to one of two groups (i.e. one taking sotagliflozin and the other the placebo) and both the medical team and participants will not know in which group each participant is until the end of the study. Participan…

This description comes directly from the study's public registry record.

Talk to the study team

Ify Mordi, MBChB, MD  ·  +44 1382 385591  ·  i.mordi@dundee.ac.uk

Always discuss trial participation with your own doctor first.

Locations (17)

Aberdeen Royal InfirmaryAberdeen, United KingdomRecruiting
Addenbrookes HospitalCambridge, United KingdomRecruiting
Ninewells HospitalDundee, United KingdomRecruiting
Royal Infirmary of EdinburghEdinburgh, United KingdomRecruiting
Glasgow Royal Infirmary, Glasgow Clinical Research FacilityGlasgow, United KingdomRecruiting
Leicester General HospitalLeicester, United KingdomRecruiting
Aintree University HospitalLiverpool, United KingdomRecruiting
Prince Philip HospitalLlanelli, United KingdomRecruiting
Guy's HospitalLondon, United KingdomRecruiting
St George's University Hospitals NHS Foundation TrustLondon, United KingdomRecruiting
Manchester Royal Infirmary HospitalManchester, United KingdomRecruiting
North Manchester General HospitalManchester, United KingdomRecruiting

+ 5 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06435156